Macrogenics shares rise 7.47% intraday after CEO to present at H.C. Wainwright 27th Annual Global Investment Conference.

miércoles, 3 de septiembre de 2025, 1:02 pm ET1 min de lectura
MGNX--
Macrogenics, Inc. rose 7.47% in intraday trading, with the company announcing that its President & Chief Executive Officer, Eric Risser, will present at the H.C. Wainwright 27th Annual Global Investment Conference on September 8, 2025. The presentation is expected to provide insights into the company's innovative antibody-based therapeutics for cancer treatment, which may have contributed to the positive market sentiment.

Macrogenics shares rise 7.47% intraday after CEO to present at H.C. Wainwright 27th Annual Global Investment Conference.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios